IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells.

作者: Janani Panneerselvam , Akhil Srivastava , Ranganayaki Muralidharan , Qi Wang , Wei Zheng

DOI: 10.18632/ONCOTARGET.11838

关键词:

摘要: // Janani Panneerselvam 1, 4 , Akhil Srivastava Ranganayaki Muralidharan Qi Wang Wei Zheng 1 Lichao Zhao Alshine Chen 3, Yan D. Anupama Munshi 2, Rajagopal Ramesh 4, 5 Department of Pathology, The University Oklahoma Health Sciences Center, City, 73104, USA 2 Radiation Oncology, 3 Biostatistics and Epidemiology, Stephenson Cancer Graduate Program in Biomedical Sciences, Correspondence to: Ramesh, email: rajagopal-ramesh@ouhsc.edu Keywords: IL-24, lung cancer, HMGA1, miR222-3p, metastasis Received: April 21, 2016     Accepted: August 24, Published: September 02, 2016 ABSTRACT Interleukin (IL)-24, a novel tumor suppressor/cytokine exhibits antitumor activity against broad-spectrum human cancer cells. In recent study, we showed that IL-24 inhibited AKT However, the molecular mechanism inhibition by remains elusive. high mobility group (HMG) A1 member non-histone chromosomal proteins commonly referred to as architectural transcription factor, regulates various genes involved cell growth survival. Overexpression HMGA1 has been shown be associated with progression several cancers, including cancer. A study demonstrated activates function reducing protein phosphatase, phosphatase 2A subunit B (PPP2R2A) via oncogenic micro (mi) RNA-222. Based on this report hypothesized IL-24-mediated HMGA1/miR-222 axis. To test our hypothesis, present used H1299 line expressed exogenous when induced doxycycline (DOX). Induction expression cells markedly reduced mRNA levels. Using mechanistic approach, found miR-222-3p -5p levels, determined qRT-PCR. Associated miR-222 was marked increase PPP2R2A, concomitant decrease phosphorylated T308/S473 expression. SiRNA-mediated knockdown combination significantly greatly migration invasion compared individual treatments. Further inhibitor increased PPP2R2A Our results demonstrate for first time inhibits regulating signaling node acts an effective suppressor. Thus, therapy combining siRNA or should treatment

参考文章(55)
Peter B Wenn, Ali R Jazirehi, Mohsen Damavand, Therapeutic implications of targeting the PI3Kinase/AKT/mTOR signaling module in melanoma therapy. American Journal of Cancer Research. ,vol. 2, pp. 178- 191 ,(2012)
Rui-Zhi Xu, Fan Li, Yu-Xia Deng, Hong-Yan Cheng, Xin-Chen Sun, Yuan-Dong Cao, Pei-Lin Huang, Zhi-Liang Jin, Shu-Kui Qin, Jun Ma, Xiao-Lin Ge, Silencing of high mobility group A1 enhances gemcitabine chemosensitivity of lung adenocarcinoma cells. Chinese Medical Journal. ,vol. 124, pp. 1061- ,(2011)
Aditi Daga, Afzal Ansari, Shanaya Patel, Sheefa Mirza, Rakesh Rawal, Valentina Umrania, Current Drugs and Drug Targets in Non-Small Cell Lung Cancer: Limitations and Opportunities Asian Pacific Journal of Cancer Prevention. ,vol. 16, pp. 4147- 4156 ,(2015) , 10.7314/APJCP.2015.16.10.4147
Janani Panneerselvam, Manish Shanker, Jiankang Jin, Cynthia D. Branch, Ranganayaki Muralidharan, Yan D. Zhao, Sunil Chada, Anupama Munshi, Rajagopal Ramesh, Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity Oncotarget. ,vol. 6, pp. 16271- 16286 ,(2015) , 10.18632/ONCOTARGET.3977
Abner M. Mhashilkar, Robert D. Schrock, Mustafa Hindi, Jennifer Liao, Kerry Sieger, Famourou Kourouma, X. Helena Zou-Yang, Eric Onishi, Oksana Takh, Thomas S. Vedvick, Gary Fanger, Lorna Stewart, Graham J. Watson, David Snary, Paul B. Fisher, Tomoyuki Saeki, Jack A. Roth, Rajagopal Ramesh, Sunil Chada, Melanoma Differentiation Associated Gene-7 (mda-7): A Novel Anti-Tumor Gene for Cancer Gene Therapy Molecular Medicine. ,vol. 7, pp. 271- 282 ,(2001) , 10.1007/BF03401847
Bethany M Bush, Ashton T Brock, Jiayue A Deng, Ronald A Nelson Jr, Takita Felder Sumter, None, The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer. Cell Biochemistry and Function. ,vol. 31, pp. 228- 236 ,(2013) , 10.1002/CBF.2876
Michael S. Hwang, Nancy Yu, Susanna Y. Stinson, Peng Yue, Robert J. Newman, Bernard B. Allan, David Dornan, miR-221/222 Targets Adiponectin Receptor 1 to Promote the Epithelial-to-Mesenchymal Transition in Breast Cancer PLoS ONE. ,vol. 8, pp. e66502- ,(2013) , 10.1371/JOURNAL.PONE.0066502
Riccardo Sgarra, Salvina Zammitti, Alessandra Lo Sardo, Elisa Maurizio, Laura Arnoldo, Silvia Pegoraro, Vincenzo Giancotti, Guidalberto Manfioletti, HMGA molecular network: From transcriptional regulation to chromatin remodeling Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. ,vol. 1799, pp. 37- 47 ,(2010) , 10.1016/J.BBAGRM.2009.08.009
Kirmani Natukula, Kaiser Jamil, Usha Rani Pingali, Venkata Satya Suresh Attili, Umamaheshwar Rao Naidu Madireddy, Survival analysis in advanced non small cell lung cancer treated with platinum based chemotherapy in combination with paclitaxel, gemcitabine and etoposide. Asian Pacific Journal of Cancer Prevention. ,vol. 14, pp. 4661- 4666 ,(2013) , 10.7314/APJCP.2013.14.8.4661